Regional differences in cortical benzodiazepine receptors of Alzheimer, vascular, and mixed dementia patients

Journal of the Neurological Sciences

Volumn 323, Issue 1-2, 2012, Pages 71-76

  Hanyu, Haruo ^a   Kume, Kazumasa ^a   Sato, Tomohiko ^a   Hirao, Kentaro ^a   Kanetaka, Hidekazu ^a   Sakurai, Hirofumi ^a   Iwamoto, Toshihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer disease; Benzodiazepine receptor; Cerebral perfusion; Mixed dementia; SPECT; Vascular dementia

Indexed keywords

BENZODIAZEPINE RECEPTOR; IOFETAMINE I 123; IOMAZENIL I 123;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; MALE; MULTIINFARCT DEMENTIA; NEUROIMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOTACTIC PROCEDURE; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN MAPPING; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DEMENTIA, VASCULAR; FEMALE; FLUMAZENIL; FRONTAL LOBE; HUMANS; IMAGING, THREE-DIMENSIONAL; IODINE RADIOISOTOPES; IOFETAMINE; MALE; NERVE TISSUE PROTEINS; ORGAN SPECIFICITY; PARIETAL LOBE; RADIOPHARMACEUTICALS; RECEPTORS, GABA-A; TEMPORAL LOBE; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84867840636     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.08.013     Document Type: Article

References (33)

1. A. Viswanathan, W.A. Rocca, and C. Tzourio Vascular risk factors and dementia. How to move forward? Neurology 72 2009 368 374
2. R.N. Kalaria, R.A. Kenny, C.G. Ballard, R. Perry, P. Ince, and T. Polvikoski Towards defining the neuropathological substrates of vascular dementia J Neurol Sci 226 2004 75 80
3. K.A. Jellinger, and J. Attems Neuropathological evaluation of mixed dementia J Neurol Sci 257 2007 80 87
4. D. Zekry, J.-J. Hauw, and G. Gold Mixed dementia: epidemiology, diagnosis, and treatment J Am Geriatr Soc 50 2002 1431 1438
5. A.D. Korczyn Mixed dementia - the most common cause of dementia Ann N Y Acad Sci 977 2002 129 134
6. K. Rockwood, C. Macknight, C. Wentzel, S. Black, R. Bouchard, and S. Gauthier The diagnosis of mixed dementia in the consortium for the investigation of vascular impairment of cognition (CIVIC) Ann N Y Acad Sci 903 2000 522 528
7. H. Tohgi, K. Chiba, K. Sasaki, S. Hiroi, and Y. Ishibashi Cerebral perfusion patterns in vascular dementia of Binswanger type compared with senile dementia of Alzheimer type: a SPECT study J Neurol 238 1991 365 370
8. H. Hanyu, S. Shimizu, Y. Tanaka, M. Takasaki, K. Koizumi, and K. Abe Cerebral blood flow patterns in Binswanger's disease: a SECT study using three-dimensional stereotactic surface projections J Neurol Sci 220 2004 79 84
9. H. Matsuda Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT J Nucl Med 48 2007 1289 1300
10. J. Nakagawara, B. Sperling, and N.A. Lassen Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil Stroke 28 1997 124 132
11. J. Hatazawa, T. Satoh, E. Shimosegawa, T. Okudera, A. Inugami, and T. Ogawa Evaluation of cerebral infarction with iodine 123I-iomazenil SPECT J Nucl Med 36 1995 2154 2161
12. I. Goethala, C. Van de Wiele, P. Boon, and R. Dierckx Is central benzodiazepine receptor imaging useful for the identification of epileptogenic foci in localization-related epilepsies? Eur J Nucl Med Mol Imaging 30 2003 325 328
13. H. Koizumi, H. Fujisawa, T. Kurokawa, E. Suehiro, H. Iwanaga, and J. Nakagawara Recovered neuronal viability revealed by iodine-123-iomazenil SPECT following traumatic brain injury J Cereb Blood Flow Metab 30 2010 1673 1681
14. K. Fukuchi, K. Hashikawa, Y. Seike, H. Moriwaki, N. Oku, and M. Ishida Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease J Nucl Med 38 1997 467 470
15. A. Soricelli, A. Postiglione, M.R. Grivet-Fojaja, P.R. Mainenti, A. Discepolo, and A. Varrone Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses Eur J Nucl Med 23 1996 1323 1328
16. A. Varrone, A. Soricelli, A. Postiglione, and M. Salvatore Comparison between cortical distribution of I-123 iomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT Clin Nucl Med 24 1999 660 665
17. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 34 1984 939 944
18. G.C. Roman, T.K. Tatemichi, T. Erkinjuntti, M.D. Cummings, M.D. Masdeu, and J.H. Garcia Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop Neurology 43 1993 250 260
19. T. Erkinjuntti, D. Inzitari, L. Pantoni, A. Wallin, P. Scheltens, and K. Rockwood Research criteria for subcortical vascular dementia in clinical trials J Neural Transm 59 2000 23 30
20. American Psychiatric Association Diagnostic and Statistical and Manual Disorders 4th ed. 1994 American Psychiatric Association Washington DC
21. M.F. Folstein, S.E. Folstein, and P.R. McHugh Mini-mental state. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
22. V.S. Hachinski, L.D. Illif, E. Zilkha, G.H. Du Boulay, V.L. McAllister, and J. Marshall Cerebral blood flow in dementia Arch Neurol 32 1975 632 637
23. S. Minoshima, K.A. Frey, R.A. Koeppe, N.L. Foster, and D.E. Kuhl A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET J Nucl Med 36 1995 1238 1248
24. J. Talairach, and P. Tournoux Co-Planar Stereotactic Atlas of the Human Brain 1998 Thieme New York
25. S. Minoshima, R.A. Koeppe, K.A. Frey, and D.E. Kuhl Anatomic standardization: linear scaling and nonlinear warping of functional brain images J Nucl Med 35 1994 1528 1537
26. M. Ihara, H. Tomimoto, K. Ishizu, T. Mukai, H. Yoshida, and N. Sawamoto Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis. A positron emission tomography study Stroke 35 2004 942 947
27. M. Ohyama, M. Senda, K. Ishiwata, S. Kitamura, M. Mishina, and K. Ishii Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF Ann Nucl Med 13 1999 309 315
28. M. Meyer, R.A. Koeppe, K.A. Frey, N.L. Foster, and D.E. Kuhl Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease Arch Neurol 52 1995 314 317
29. A/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment Eur J Nucl Med Mol Imaging 37 2010 1156 1163
30. H.C. Chui, J.I. Victoroff, D. Margolin, W. Jagust, R. Shankle, and R. Katzman Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's Disease Diagnostic and Treatment Centers Neurology 42 1992 473 480
31. World Health Organization The ICD-10 Classification of Mental and behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines 1992 World Health Organization Geneva, Switzerland 50 51
32. T. Pohjasvaara, R. Mantyla, R. Ylikoski, M. Kaste, and T. Erkinjuntti Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN), DSM-IV) for the diagnosis of vascular dementia Stroke 31 2000 2952 2957
33. M. Weih, U. Degirmenci, S. Kreil, G. Suttner, D. Schmidt, and J. Kornhuber Nuclear medicine diagnostic techniques in the era of pathophysiology-based CSF biomarkers for Alzheimer's disease J Alzheimers Dis 26 Suppl. 3 2011 97 103